206 related articles for article (PubMed ID: 15576061)
1. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.
Perlman WR; Webster MJ; Kleinman JE; Weickert CS
Biol Psychiatry; 2004 Dec; 56(11):844-52. PubMed ID: 15576061
[TBL] [Abstract][Full Text] [Related]
2. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
[TBL] [Abstract][Full Text] [Related]
3. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
Webster MJ; Knable MB; O'Grady J; Orthmann J; Weickert CS
Mol Psychiatry; 2002; 7(9):985-94, 924. PubMed ID: 12399952
[TBL] [Abstract][Full Text] [Related]
4. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Carletti R; Corsi M; Melotto S; Caberlotto L
Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098
[TBL] [Abstract][Full Text] [Related]
6. Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives.
Matsubara T; Funato H; Kobayashi A; Nobumoto M; Watanabe Y
Biol Psychiatry; 2006 Apr; 59(8):689-95. PubMed ID: 16458268
[TBL] [Abstract][Full Text] [Related]
7. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
8. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
[TBL] [Abstract][Full Text] [Related]
9. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
10. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia.
Weidenhofer J; Yip J; Zavitsanou K; Huang XF; Chahl LA; Tooney PA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1313-21. PubMed ID: 16815618
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder.
Klok MD; Alt SR; Irurzun Lafitte AJ; Turner JD; Lakke EA; Huitinga I; Muller CP; Zitman FG; de Kloet ER; Derijk RH
J Psychiatr Res; 2011 Jul; 45(7):871-8. PubMed ID: 21195417
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder.
Hamazaki K; Hamazaki T; Inadera H
J Psychiatr Res; 2012 Aug; 46(8):1024-8. PubMed ID: 22572570
[TBL] [Abstract][Full Text] [Related]
14. Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment.
Young LT; Bezchlibnyk YB; Chen B; Wang JF; MacQueen GM
Biol Psychiatry; 2004 Mar; 55(6):570-7. PubMed ID: 15013825
[TBL] [Abstract][Full Text] [Related]
15. Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients.
Varea E; Guirado R; Gilabert-Juan J; Martí U; Castillo-Gomez E; Blasco-Ibáñez JM; Crespo C; Nacher J
J Psychiatr Res; 2012 Feb; 46(2):189-97. PubMed ID: 22099865
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
Munakata K; Iwamoto K; Bundo M; Kato T
Biol Psychiatry; 2005 Mar; 57(5):525-32. PubMed ID: 15737668
[TBL] [Abstract][Full Text] [Related]
17. Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder.
Bezchlibnyk YB; Sun X; Wang JF; MacQueen GM; McEwen BS; Young LT
J Psychiatry Neurosci; 2007 May; 32(3):203-10. PubMed ID: 17476367
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
19. In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus.
Wang X; Dow-Edwards D; Anderson V; Minkoff H; Hurd YL
Biol Psychiatry; 2004 Dec; 56(12):909-15. PubMed ID: 15601599
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia.
Pongrac JL; Middleton FA; Peng L; Lewis DA; Levitt P; Mirnics K
Biol Psychiatry; 2004 Dec; 56(12):943-50. PubMed ID: 15601604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
